(Q33850709)

29 July 2017

1 reference

title

Pathogenesis of Guillain-Barré syndrome (English)

1 reference

29 July 2017

0 references

Guillain–Barré syndrome

0 references

author name string

Hughes RA

1

1 reference

29 July 2017

Hadden RD

2

1 reference

29 July 2017

Gregson NA

3

1 reference

29 July 2017

Smith KJ

4

1 reference

29 July 2017

1 December 1999

1 reference

Journal of Neuroimmunology

29 July 2017

1 reference

29 July 2017

100

1 reference

29 July 2017

74-97

1 reference

29 July 2017

1-2

1 reference

Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The role of integrins in immune-mediated diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Campylobacter serology in patients with Chinese paralytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Factors in the cerebrospinal fluid of multiple sclerosis patients interfering with voltage-dependent sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

On the nature of endogenous antiexcitatory factors in the cerebrospinal fluid of patients with demyelinating neurological disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Demyelination in vivo by Guillain-Barré syndrome and other human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

An ultrastructural study of an acute fatal case of the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Chronic relapsing axonal neuropathy: a first case report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

A cytotonic, cholera toxin-like protein produced by Campylobacter jejuni

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

High-titer selective serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Quantitative analysis of endoneurial T-cells in human sural nerve biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barré syndrome with ophthalmoplegia: clinicopathologic study of the central and peripheral nervous systems, including the oculomotor nerves.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Passive transfer studies in Guillain-Barré polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

An acute axonal form of Guillain-Barré polyneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Bovine gangliosides and acute motor polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Severe Guillain-Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Induction of experimental autoimmune neuritis with peripheral myelin protein-22.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

HLA-DR antigens in Mexican patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Some immunological properties of antisera raised against the trisialoganglioside GT1B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Pathology of the motor-sensory axonal Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Peripheral nerve conduction in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Glycosphingolipids in cellular interaction, differentiation, and oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Motor nerve biopsy in severe Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Demyelination induced by serum from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Serum levels of soluble E-selectin (ELAM-1) in immune-mediated neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Patterns of recovery in the Guillain-Barre syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Experimental campylobacter infection and diarrhoea in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Clinical and epidemiologic features of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Immune responses to myelin antigens in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Subacute Idiopathic Demyelinating Polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Sural nerve biopsies in Guillain-Barre syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Liquorpheresis eliminates blocking factors from cerebrospinal fluid in polyradiculoneuritis (Guillain-Barré syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibodies to sulfated glycolipids in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Anti-GM1 IgA antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Electrophysiologic studies in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

IgG anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

HLA antigens in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

T cell responses to myelin proteins in Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

T cell receptor V beta gene usage in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The distribution of CD1 molecules in inflammatory neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barré and Fisher's syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Localization of GM1 and GD1b antigens in the human peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Experimental sensory neuropathy induced by sensitization with ganglioside GD1b.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Binding of antibodies against GM1 and GD1b in human peripheral nerve.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Complement-fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Gangliosides offer partial protection in experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Serum-mediated Schwann cell cytotoxicity in the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Endoneurial effects of sera from patients with acute inflammatory polyradiculoneuropathy: electrophysiologic studies on normal and demyelinated rat nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Configuration and interaction of the polar head group in gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Thirty-eight cases of the Guillain-Barre syndrome: an immunological study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Treatment of acute pandysautonomia with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

P0 myelin protein produces experimental allergic neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Characterization of anti-ganglioside antibodies present in normal human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Pathology of acute and chronic ischaemic neuropathy in atherosclerotic peripheral vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Conformational analysis of blood group A-active glycosphingolipids using HSEA-calculations. The possible significance of the core oligosaccharide chain for the presentation and recognition of the A-determinant.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barré syndrome: demonstration of antibodies to peripheral nerve tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Different ceramide compositions of gangliosides between human motor and sensory nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

In vivo effects of sera from Guillain-Barré subgroups: an electrophysiological and histological study on rat nerves.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Atypical Miller Fisher syndrome with GQ1b antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The role of nitric oxide in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

T lymphocyte recognition sites on peripheral nerve myelin P0 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Neuropathological findings in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Pathology of the Guillain-Barr� syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Gangliosides and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Campylobacter jejuni infection and Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Electrophysiologic studies in the Guillain-Barré syndrome: Effects of plasma exchange and antibody rebound

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Extra- and intrathecal production of antinerve and antibrain antibodies in Guillain-Barré syndrome: evaluation by an antibody index.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Association between oral poliovaccine and Guillain-Barré syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Guillain-Barré syndrome after varicella-zoster infection. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Experimental conduction block induced by serum from a patient with anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

In vitro demyelination by serum antibody from patients with guillain-barré syndrome requires terminal complement complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Synergy between antibody and P2-reactive T cells in experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Intraneural activated T cells cause focal breakdown of the blood-nerve barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Cholinergic neuron-specific ganglioside GQ1b alpha a possible target molecule for serum IgM antibodies in some patients with sensory ataxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Myelin- and microbe-specific antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Humoral factors in peripheral nerve disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Anti-sulphatide antibodies in peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Features of the Guillain-Barré syndrome in mice following intraperitoneal injection of patient serum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by a mixed haemagglutination technique

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

A comparative study of experimental allergic neuritis in the rabbit, guinea pig, and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

An electrophysiological and histological study of trypsin induced demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Gangliosides and bacterial toxins in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Acute sensory neuropathy in an adolescent girl following BCG vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Familial Guillain-Barre Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

HLA antigens in the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

A prospective study of acute idiopathic neuropathy. III. Immunological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

A prospective study of acute idiopathic neuropathy. II. Antecedent events

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Landry-Guillain-Barré syndrome. A primary demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Acute cytomegalovirus infection and IgM anti-GM2 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Effects of ganglioside administration on experimental autoimmune neuritis induced by peripheral nerve myelin or P2-specific T cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

Immune reactions to P2 protein in human inflammatory demyelinative neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900195-2

7 January 2021

10.1016/S0165-5728(99)00195-2

Identifiers

DOI

1 reference

29 July 2017

1 reference